From Healthcare & Pharma and USA - 20 Oct 2014 08:11 EDT Shire sets sights on US rivals Add to My Stories Print page Add to Favourites The UK-based drugmaker Shire appears to be wasting no time in looking at possible ways to put the potential US$1.6bn break fee it could receive from AbbVie – as a…